• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动与缺血性卒中风险:在 CHA2DS2-VASc 评分为 0 或 1 的患者中是否仍有意义?

Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1?

机构信息

Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei, Taiwan.

出版信息

Stroke. 2012 Oct;43(10):2551-5. doi: 10.1161/STROKEAHA.112.667865. Epub 2012 Aug 7.

DOI:10.1161/STROKEAHA.112.667865
PMID:22871677
Abstract

BACKGROUND AND PURPOSE

Atrial fibrillation (AF) is an independent risk factor for stroke. Recent studies have demonstrated that the CHA(2)DS(2)-VASc scheme is useful for selecting patients who are truly at low risk. The goal of the present study was to compare the risk of ischemic stroke among AF patients with a CHA(2)DS(2)-VASc score of 0 (male) or 1 (female) with those without AF.

METHODS

The study enrolled 509 males (CHA(2)DS(2)-VASc score=0) and 320 females (CHA(2)DS(2)-VASc score=1) with AF who did not receive any antithrombotic therapy. Patients were selected from the National Health Insurance Research Database in Taiwan. For each study patient, 10 age-matched and sex-matched subjects without AF and without any comorbidity from the CHA(2)DS(2)-VASc scheme were selected as controls. The clinical end point was the occurrence of ischemic stroke.

RESULTS

During a follow-up of 57.4 ± 35.7 months, 128 patients (1.4%) experienced ischemic stroke. The event rate did not differ between groups with and without AF for male patients (1.6% vs 1.6%; P=0.920). In contrast, AF was a significant risk factor for ischemic stroke among females (hazard ratio, 7.77), with event rates of 4.4% and 0.7% for female patients with and without AF (P<0.001).

CONCLUSIONS

AF males with a CHA(2)DS(2)-VASc score of 0 were at true low risk for stroke, which was similar to that of non-AF patients. However, AF females with a score of 1 were still at higher risk for ischemic events than non-AF patients.

摘要

背景与目的

心房颤动(AF)是中风的独立危险因素。最近的研究表明,CHA (2 ) DS (2 ) -VASc 方案可用于选择真正低危患者。本研究的目的是比较 CHA (2 ) DS (2 ) -VASc 评分为 0 (男性)或 1 (女性)的 AF 患者与无 AF 患者发生缺血性中风的风险。

方法

本研究纳入了 509 名男性(CHA (2 ) DS (2 ) -VASc 评分= 0 )和 320 名女性(CHA (2 ) DS (2 ) -VASc 评分= 1 ),这些患者患有 AF 但未接受任何抗血栓治疗。患者选自台湾全民健康保险研究数据库。每位研究患者均选择了 10 名年龄和性别匹配且无 AF 且无 CHA (2 ) DS (2 ) -VASc 方案中任何合并症的患者作为对照。临床终点为缺血性中风的发生。

结果

在 57.4 ± 35.7 个月的随访期间,128 名患者(1.4 %)发生缺血性中风。对于男性患者,有无 AF 组之间的事件发生率无差异(1.6 %与 1.6 %; P=0.920 )。相比之下,AF 是女性发生缺血性中风的重要危险因素(风险比,7.77 ),有 AF 和无 AF 的女性患者的事件发生率分别为 4.4 %和 0.7 %( P<0.001 )。

结论

CHA (2 ) DS (2 ) -VASc 评分 0 的 AF 男性患者发生中风的风险确实较低,与非 AF 患者相似。但是,评分 1 的 AF 女性患者发生缺血性事件的风险仍高于非 AF 患者。

相似文献

1
Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1?心房颤动与缺血性卒中风险:在 CHA2DS2-VASc 评分为 0 或 1 的患者中是否仍有意义?
Stroke. 2012 Oct;43(10):2551-5. doi: 10.1161/STROKEAHA.112.667865. Epub 2012 Aug 7.
2
Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?用于心房颤动中风风险分层的CHADS2和CHA2DS2-VASc评分比较:亚洲人应使用哪种评分系统?
Heart Rhythm. 2016 Jan;13(1):46-53. doi: 10.1016/j.hrthm.2015.08.017. Epub 2015 Aug 12.
3
Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.需要透析的终末期肾病房颤患者缺血性卒中的发病率及预测
Heart Rhythm. 2014 Oct;11(10):1752-9. doi: 10.1016/j.hrthm.2014.06.021. Epub 2014 Jun 18.
4
Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?对于 CHA2DS2-VASc 评分(除性别以外)有 1 个额外危险因素的房颤患者,是否应接受口服抗凝治疗?
J Am Coll Cardiol. 2015 Feb 24;65(7):635-42. doi: 10.1016/j.jacc.2014.11.046.
5
Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study.CHA2DS2-VASc评分为0或1的房颤患者急性心肌梗死:一项全国性队列研究
Heart Rhythm. 2014 Nov;11(11):1941-7. doi: 10.1016/j.hrthm.2014.08.003. Epub 2014 Aug 5.
6
Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan.年龄对房颤患者中风风险的影响:来自台湾的全国队列研究。
J Am Coll Cardiol. 2015 Sep 22;66(12):1339-47. doi: 10.1016/j.jacc.2015.07.026.
7
Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.可靠识别最初诊断为“孤立”心房颤动患者中的“真正低”血栓栓塞风险:贝尔格莱德心房颤动研究。
Circ Arrhythm Electrophysiol. 2012 Apr;5(2):319-26. doi: 10.1161/CIRCEP.111.966713. Epub 2012 Feb 8.
8
Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.房颤脑卒中患者中 CHADS2 评分与 CHA2DS2-VASc 评分的比较。
Eur J Neurol. 2013 Apr;20(4):623-8. doi: 10.1111/j.1468-1331.2012.03807.x. Epub 2012 Jul 27.
9
CHADS-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.亚洲房颤患者卒中的CHADS-VASc评分(充血性心力衰竭、高血压、年龄≥75岁[加倍]、糖尿病、既往卒中或短暂性脑缺血发作[加倍]、血管疾病、年龄65 - 74岁、女性):一项韩国全国性样本队列研究。
Stroke. 2017 Jun;48(6):1524-1530. doi: 10.1161/STROKEAHA.117.016926. Epub 2017 Apr 28.
10
Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.尽管接受了口服抗凝治疗,但CHA2DS2-VASc评分对房颤高危卒中患者的预测价值。
Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. Epub 2012 May 18.

引用本文的文献

1
Direct oral anticoagulants in embolic stroke of undetermined source: an updated meta-analysis.直接口服抗凝剂用于不明来源栓塞性卒中:一项更新的荟萃分析。
J Thromb Thrombolysis. 2024 Oct;57(7):1163-1171. doi: 10.1007/s11239-024-03017-7. Epub 2024 Jul 29.
2
HbA1c and risk factors' prevalence in patients with stroke: a retrospective study in a tertiary care hospital in Saudi Arabia.HbA1c 与沙特阿拉伯一家三级护理医院中风患者的危险因素流行情况:一项回顾性研究。
Neurosciences (Riyadh). 2024 Jan;29(1):18-24. doi: 10.17712/nsj.2024.1.20230037.
3
The Brain-Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease.
脑心轴:心血管疾病中的神经炎症相互作用。
Curr Cardiol Rep. 2023 Dec;25(12):1745-1758. doi: 10.1007/s11886-023-01990-8. Epub 2023 Nov 23.
4
Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.亚洲心房颤动患者的临床表现、治疗和结局的性别差异:前瞻性亚太心律学会心房颤动登记研究报告。
Sci Rep. 2023 Oct 26;13(1):18375. doi: 10.1038/s41598-023-45345-3.
5
Association Between Onset of Type 2 Diabetes and Risk of Atrial Fibrillation in New Zealanders With Impaired Glucose Tolerance Over 25 Years.25 年来,新西兰葡萄糖耐量受损人群中 2 型糖尿病发病与心房颤动风险的相关性。
J Am Heart Assoc. 2023 Sep 19;12(18):e030159. doi: 10.1161/JAHA.123.030159. Epub 2023 Sep 13.
6
High-Sensitivity C-Reactive Protein Modifies P-Wave Terminal Force in Lead V1-Associated Prognosis in Acute Ischemic Stroke or TIA Patients.高敏C反应蛋白改变急性缺血性卒中或短暂性脑缺血发作患者V1导联P波终末电势相关的预后
J Clin Med. 2023 Mar 3;12(5):2031. doi: 10.3390/jcm12052031.
7
Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response.性别差异与心房颤动:从血栓栓塞风险到抗凝治疗反应。
Medicina (Kaunas). 2023 Jan 28;59(2):254. doi: 10.3390/medicina59020254.
8
Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain.直接作用口服抗凝剂在老年房颤患者中的应用:西班牙的一项多中心横断面研究。
J Clin Med. 2023 Feb 3;12(3):1224. doi: 10.3390/jcm12031224.
9
Smoking Affects the Post-Stroke Inflammatory Response of Lipid Mediators in a Gender-Related Manner.吸烟以与性别相关的方式影响中风后脂质介质的炎症反应。
Biomedicines. 2022 Dec 29;11(1):92. doi: 10.3390/biomedicines11010092.
10
Hyperuricemia Is Associated With the Risk of Atrial Fibrillation Independent of Sex: A Dose-Response Meta-Analysis.高尿酸血症与心房颤动风险相关,与性别无关:一项剂量反应荟萃分析。
Front Cardiovasc Med. 2022 Apr 7;9:865036. doi: 10.3389/fcvm.2022.865036. eCollection 2022.